Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Classical hematology 1

Conditions

Surgical Wound Infection 2Rectal Neoplasms 1Intestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 213Irinotecan 146Leucovorin 140Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Bevacizumab 99Drug Therapy 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Anti-Bacterial Agents × Gastrointestinal × Clear all
NCT03563586 2020-09-11

MECCA

National and Kapodistrian University of Athens

Phase NA Unknown
210 enrolled
Gastrointestinal

Intestinal Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

NCT03436719 2019-03-05

Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics.

State Scientific Centre of Coloproctology, Russian Federation

Phase NA Unknown
280 enrolled
Gastrointestinal

Rectal Neoplasms, Surgical Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡